Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
microRNA 31 | 0.471 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||
|
microRNA 320a | 0.526 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
matrix metallopeptidase 12 | 0.484 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | |||||||||
|
POTE ankyrin domain family member K, pseudogene | 0.542 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
mannose-binding lectin family member 3, pseudogene | 0.518 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | |||||||||
|
microRNA 499a | 0.519 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
ARAF pseudogene 2 | 0.931 | 0.077 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
tRNA-Cys (GCA) 24-1 | 0.729 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | |||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
lipoprotein(a) | 0.444 | 0.769 | 6.6E-89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
disease | 0.010 | None | 1.000 | 1 | 3 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily A member 4 | 0.493 | 0.769 | 5.3E-48 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2000 | 2000 | ||||||||
|
sialic acid binding Ig like lectin 1 | 0.597 | 0.654 | 5.3E-46 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
MYB binding protein 1a | 0.695 | 0.615 | 5.2E-42 |
|
disease | 0.020 | None | 1.000 | 2 | 2 | 2013 | 2016 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
complement C3b/C4b receptor 1 (Knops blood group) | 0.533 | 0.808 | 1.6E-35 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2004 | 2013 | ||||||||
|
phosphodiesterase 6B | 0.626 | 0.346 | 2.6E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
solute carrier family 34 member 1 | 0.619 | 0.423 | 8.9E-27 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
alkylglycerol monooxygenase | 0.780 | 0.423 | 6.8E-26 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
toll like receptor 1 | 0.496 | 0.808 | 5.9E-23 |
|
disease | 0.060 | None | 1.000 | 6 | 7 | 2010 | 2016 | ||||||||
|
solute carrier family 22 member 1 | 0.556 | 0.731 | 1.5E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
shortage in chiasmata 1 | 0.780 | 0.385 | 3.7E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
MOK protein kinase | 0.476 | 0.769 | 8.8E-22 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.050 | None | 1.000 | 5 | 2 | 2009 | 2017 |